CSU logo TB Vaccine Testing and Research Materials Contract
Home
Vaccine Testing
Research Materials
  Materials Available
 
Links
Contacts
Frequently Asked Questions
Publications
BEI Resources Transition

Attention

The TB Contract is no longer taking requests for research materials. All materials are now available through the Biodefense and Emerging Infections Research Resources Repository (BEI Resources).

Genomic DNA

Reagent:
Genomic DNA

Default Quantity:
100 µg

Strains available:
H37Rv and Clinical isolate CSU93 (KY/TN 95-031551, CDC 1551)

Production system:
The bacilli are grown to late-log phase (day 14) in glycerol-alanine-salts (GAS) medium and harvested by centrifugation. Cell lipids are removed by chloroform/methanol (2:1) extraction in an equal volume of Tris-EDTA buffer. Delipidated cells are exposed to lysozyme and RNase overnight followed by SDS and Proteinase K treatment. Genomic DNA is isolated from contaminating proteins using organic extraction. To remove polysaccharide contaminants, DNA is precipitated with isopropanol and stored at 4°C as a dry pellet.

Notes:
Quality control for this reagent includes agarose gel electrophoresis and spectrophotometric analysis

References:
Belisle, J.T., and Sonnenberg, M.G., Methods Mol. Biol. 101:31, 1998.

 

Return to Materials Available